Efficacy of 177-Lutetium DOTATATE Peptide Receptor Radionuclide Therapy in patients with metastatic NENs and carcinoid syndrome refractory to somatostatin analogues

被引：0
|
作者：
Ratnayake, G. M. [1 ]
Koffas, A. [1 ]
Theocharopoulos, I [1 ]
Hayes, A. [1 ]
Navalkissoor, S. [1 ]
Gnanasegaran, G. [1 ]
Quigley, A. M. [1 ]
Khoo, B. [1 ]
Mandair, D. [1 ]
Grossman, A. [1 ]
Caplin, M. [1 ]
Alsadik, S. [1 ]
Clark, R. [1 ]
Toumpanakis, C. [1 ]
机构：
[1] Royal Free Hosp, ENETS Ctr Excellence, London, England
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2022年 / 34卷
关键词：
carcinoid syndrome; prrt;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H24
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [41] Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
    Mina M. Swiha
    Duncan E. K. Sutherland
    Golmehr Sistani
    Alireza Khatami
    Rami M. Abazid
    Amol Mujoomdar
    Daniele P. Wiseman
    Jonathan G. Romsa
    Robert H. Reid
    David T. Laidley
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 225 - 236
  • [42] In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy
    Sygula, Aleksandra
    Ledwon, Aleksandra
    Hasse-Lazar, Kornelia
    Jurecka-Lubieniecka, Beata
    Michalik, Barbara
    Paliczka-Cieslik, Ewa
    Zeman, Marcin
    Chmielik, Ewa
    Sczasny, Monika
    Jarzab, Barbara
    Handkiewicz-Junak, Daria
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (11) : 3841 - 3851
  • [43] Metastatic Insulinoma Controlled by Targeted Radionuclide Therapy With 177Lu-DOTATATE in a Patient With Solitary Kidney and MEN-1 Syndrome
    Novruzov, Fuad
    Mehmetbeyli, Leyla
    Aliyev, Jamil A.
    Abbasov, Bahadur
    Mehdi, Elnur
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E415 - E417
  • [44] Safety and efficacy of peptide radionuclide therapy (PRRT) with 177Lu-DOTATATE for Japanese patients with neuroendocrine neoplasm (NEN): A single-center retrospective study
    Okamoto, K.
    Hijioka, S.
    Goto, Y.
    Honma, Y.
    Hirano, H.
    Shoji, H.
    Sudo, K.
    Shimoi, T.
    Yonemori, K.
    Ito, K.
    Morizane, C.
    Okusaka, T.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 211 - 211
  • [45] Pharmacokinetic digital phantoms for accuracy assessment of image-based dosimetry in 177Lu-DOTATATE peptide receptor radionuclide therapy
    Brolin, Gustav
    Gustafsson, Johan
    Ljungberg, Michael
    Gleisner, Katarina Sjogreen
    PHYSICS IN MEDICINE AND BIOLOGY, 2015, 60 (15): : 6131 - 6149
  • [46] Real-life efficacy and toxicity of lutetium peptide receptor radionuclide therapy in patients with progressive, metastatic neuroendocrine tumors who failed at least one line of systemic treatment
    Kavan, P.
    Rho, H.
    Probst, S.
    Abikhzer, G.
    Rho, Y. S.
    Barrera, I
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 193 - 193
  • [47] Single centre retrospective review of outcome of 177Lu-DOTATATE peptide receptor radionuclide therapy in the treatment of progressive metastatic neuroendocrine tumours: Survival, toxicity, and prognostic factors
    Alsadik, Shahad
    Gnanasegaran, Gopinath
    Chen, Luohai
    Quigley, Ann-Marie
    Mandair, Dalvinder
    Toumpanakis, Christos
    Caplin, Martyn
    Navalkissoor, Shaunak
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 (11)
  • [48] Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors
    Bergsma, Hendrik
    van Lom, Kirsten
    Raaijmakers, Marc H. G. P.
    Konijnenberg, M.
    Kam, B. L. Boen L. R.
    Teunissen, Jaap J. M.
    de Herder, Wouter W.
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 452 - 458
  • [49] Efficacy of 177Lu Peptide Receptor Radionuclide Therapy for the Treatment of Neuroendocrine Tumors A Meta-analysis
    Saravana-Bawan, Bianka
    Bajwa, Amandeep
    Paterson, John
    McEwan, Alexander J. B.
    McMullen, Todd P. W.
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 719 - 727
  • [50] Efficacy of Peptide Receptor Radionuclide Therapy in Patients with Advanced Bronchial Neuroendocrine Tumours
    Koffas, A.
    Popat, R.
    Mohmaduvesh, M.
    Quigley, A. M.
    Navalkissoor, S.
    Caplin, M.
    Toumpanakis, C.
    NEUROENDOCRINOLOGY, 2016, 103 : 81 - 81
12345